The Journal of Contemporary Dental Practice

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 19 , ISSUE 8 ( 2018 ) > List of Articles


New Directions for Oral Submucous Fibrosis Research: Whole Evaluation for Holistic Rehabilitation!

Keywords : Betel-quid, Meditation, Mind, Quality-of-life.

Citation Information : New Directions for Oral Submucous Fibrosis Research: Whole Evaluation for Holistic Rehabilitation!. J Contemp Dent Pract 2018; 19 (8):901-903.

DOI: 10.5005/jp-journals-10024-2354

License: CC BY-NC 3.0

Published Online: 01-03-2018

Copyright Statement:  Copyright © 2018; The Author(s).


Oral submucous fibrosis (OSF) is an oral potentially malignant disorder (OPMD) associated with prolonged betel-quid (BQ) use. It affects both physiological and psychological dimensions, leading to a significant morbidity. Some challenges in OSF research include: Assessment and correction of: (i) Quality of life, (ii) burning sensation, and (iii) nutritional deficiency. There are numerous medical treatments for OSF, but most of them fail to offer complete rehabilitation. This is because some underpinnings of this condition like “mental factors” that contribute to habit continuation at root level, “poor quality of life,” and “nutritional deficiencies” are still uncorrected. We believe that OSF must be managed at the “mind and body” level to accomplish holistic rehabilitation. Herein, we briefly describe the general condition of OSF patients, and highlight the possibility of a novel telomere-based assessment of psychosocial stress, and support use of meditation to counter excessive “telomere shortening” which is linked to oral cancer. We also expand the current view on “burning sensation” in OSF from an entire physical concept to a possibility of mental factors, and finally recommend rich, micronutrient supplementation (through diet) to counter free radical production within the hypoxic oral epithelium.

PDF Share
  1. Wei YT, Chou YT, Yang YC, Chou CY, Lu FH, Chang CJ, Wu JS. Betel nut chewing associated with increased risk of arterial stiffness. Drug Alcohol Depend 2017 Nov;180:1-6.
  2. Yuan F, Zhu X, Kong L, Shen H, Liao W, Jiang C. White matter integrity deficit associated with betel quid dependence. Front Psychiatry 2017 Oct;8:201.
  3. Osborne PG, Chou TS, Shen TW. Characterization of the psychological, physiological and EEG profile of acute betel quid intoxication in naïve subjects. PLoS One 2011 Aug;6(8):e23874.
  4. Kanodia S, Giri VP, Giri OP, Devi MP, Garima Y. Assessment of anxiety, depression, and serum cortisol level in oral submucous fibrosis patients: a controlled clinical trial. Eur J Dent 2017 Jul-Sep;11(3):293-298.
  5. Bau DT, Lippman SM, Xu E, Gong Y, Lee JJ, Wu X, Gu J. Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinoma. Cancer 2013 Dec;119(24):4277-4283.
  6. Jacobs TL, Epel ES, Lin J, Blackburn EH, Wolkowitz OM, Bridwell DA, Zanesco AP, Aichele SR, Sahdra BK, MacLean KA, et al. Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology 2011 Jun;36(5):664-681.
  7. Steptoe A, Hamer M, Lin J, Blackburn EH, Erusalimsky JD. The longitudinal relationship between cortisol responses to mental stress and leukocyte telomere attrition. J Clin Endocrinol Metab 2017 Mar;102(3):962-969.
  8. Sarode SC, Panta P, Sarode GS, Gadbail AR, Gondivkar SM, Patil S. New research directions for areca nut/betel quid and oral submucous fibrosis for holistic prevention and treatment. Oral Oncol 2018 Mar;78:218-219.
  9. Panta P, Sarode SC, Sarode GS, Gadbail AR, Gondivkar SM, Patin S. “Mind” in betel-quid use and related disorders. J Contemp Dent Pract 2018 Jun;19(6):1-2.
  10. Sarode SC, Sarode GS. Primary burning mouth syndrome in oral submucous fibrosis patients. Oral Oncol 2011 Jul;47(7):683.
  11. Sarode SC, Sarode GS. Burning sensation in oral submucous fibrosis and its possible association with mucin secreted by affected minor salivary glands. Oral Oncol 2013 Apr;49(4):e16-e17.
  12. Rao PK. Efficacy of alpha lipoic acid in adjunct with intralesional steroids and hyaluronidase in the management of oral submucous fibrosis. J Cancer Res Ther 2010 Oct-Dec;6(4):508-510.
  13. Maher R, Aga P, Johnson NW, Sankaranarayanan R, Warnakulasuriya S. Evaluation of multiple micronutrient supplementation in the management of oral submucous fibrosis in Karachi, Pakistan. Nutr Cancer 1997;27(1):41-47.
  14. Wang YP, Wu YC, Cheng SJ, Chen HM, Sun A, Chang JY. High frequencies of vitamin B12 and folic acid deficiencies and gastric parietal cell antibody positivity in oral submucous fibrosis patients. J Formos Med Assoc 2015 Sep;114(9):813-819.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.